C07C 233/56
Having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl
Official title: having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides
C07C233/56 (Having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl) appears on 153 US grants and 137 published applications in this corpus.
Search patents in C07C- Granted patents
- 153
- Published applications
- 137
- Assignees
- 106
- Inventors
- 483
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 9 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 10 |
| 2003 | 5 | 5 |
| 2004 | 3 | 2 |
| 2005 | 5 | 7 |
| 2006 | 2 | 2 |
| 2007 | 1 | 2 |
| 2008 | 1 | 3 |
| 2009 | 0 | 5 |
| 2010 | 3 | 6 |
| 2011 | 2 | 2 |
| 2012 | 3 | 4 |
| 2013 | 3 | 7 |
| 2014 | 9 | 13 |
| 2015 | 7 | 8 |
| 2016 | 11 | 11 |
| 2017 | 15 | 16 |
| 2018 | 6 | 7 |
| 2019 | 3 | 4 |
| 2020 | 5 | 8 |
| 2021 | 4 | 5 |
| 2022 | 7 | 5 |
| 2023 | 6 | 4 |
| 2024 | 4 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Cyclic diones as herbicidal compounds3 Jun 2025US 12,319,640 B2Syngenta Crop Protection AG
- Caspase inhibitors and methods of use thereof27 Aug 2024US 12,071,412 B2NOBO Medicine Inc.
- Substituted amide compounds useful as farnesoid X receptor modulators9 Jul 2024US 12,030,835 B2Bristol-Myers Squibb Company
- Neprilysin inhibitors25 Jun 2024US 12,016,835 B2Theravance Biopharma R&D IP, LLC
- Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith25 Jun 2024US 12,017,975 B2The University of British Columbia
- Covalent Inhibitors As Antiviral Agents3 Oct 2024US 2024/0327334 A1Enanta Pharmaceuticals, Inc.
- Hybrid carriers for nucleic acid cargo28 Sep 2023US 2023/0302146 A1CureVac AG
- Neprilysin inhibitors14 Sep 2023US 2023/0285340 A1Theravance Biopharma R&D IP, LLC
- Caspase inhibitors and methods of use thereof10 Aug 2023US 2023/0250067 A1Histogen, Inc.
- Myc-max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith4 May 2023US 2023/0134821 A1The University of British Columbia
Most cited
By later US patents
- Immunosuppressive compounds109US 5,192,773 AVertex Pharmaceuticals Incorporated · 1993
- Immunosuppressive compounds94US 5,330,993 AVertex Pharmaceuticals Incorporated · 1994
- Immunosuppressive compounds81US 5,516,797 AVertex Pharmaceuticals Incorporated · 1996
- Neprilysin inhibitors56US 8,691,868 B2Theravance, Inc. · 2014
- Nitric oxide donor neprilysin inhibitors53US 9,045,443 B2Theravance Biopharma R&D IP, LLC · 2015